Global expansion Chanelle Pharma is expanding its global footprint with operations in Ireland, the UK, Portugal, and Jordan and supplies products to more than 90 countries. This presents a sales opportunity to collaborate on international supply chains, co-development, and cross-border distribution partnerships, especially for high-demand human and animal health products.
CFO leadership Recent appointment of a new Chief Financial Officer signals a focus on financial strategy, investment, and global growth. This creates an opening to engage in strategic funding discussions, premium partnerships, and capital-efficient manufacturing programs that align with Chanelle’s expansion plans.
ERP modernization Implementation of SAP Cloud ERP Private and collaboration with SAP Signavio for CDMO processes indicate a modernization push. Sales opportunities exist to offer advanced manufacturing technologies, integration services, and analytics solutions that optimize cost, compliance, and throughput in pharmaceutical manufacturing.
Animal health focus Appointment of a Head of Animal Health and emphasis on the animal health division suggests growing demand in this segment. This presents opportunities to offer dedicated formulations, contract manufacturing, supply chain optimization, and regulatory-compliant packaging tailored to animal health products.
Integrated partner Chanelle positions itself as an end-to-end, fully integrated partner across development, manufacturing, and commercialization. This creates a cross-sell path for services such as clinical development support, advanced analytics, digital marketing, and wholesale/market access solutions to deepen partner relationships and expand contract opportunities.